DNAVision is an Affymetrix official service provider since 2003 for the GeneChip® series of products. GeneChip®-based genome-wide expression profiling is available to both academic and industrial customers. Several thousands of GeneChip® and several hundreds of projects have been successfully run to completion
We provide a complete service program based on the Affymetrix GeneChip®, giving our customers access to the latest technologies, without them having to invest heavily in resources.
We provide a comprehensive range of support - from guidance in study design, experiment planning and laboratory work, to data analysis and mining, and preparation of publications.
We are not a simple service provider but a real partner providing added value to your research.
Starting from very low quantity of total RNA (from 5 ng), we can run
very robust and cost effective protocol to give you the confidence and
turn-around time critical for a successful experiment.
A) Sample reception
Target preparation utilizing either :
As recommended by Affymetrix, several quality controls (QC) are performed while processing the samples. These QCs include spike-in controls or in-process sample controls. After image processing, a detailed QC report is generated and sent along with the results. Thus you’ll be informed about any potential bias before performing statistical analysis of your data
The MicroArray Quality (MAQC) ProjectThe MicroArray Quality Consortium (MAQC) project (http://www.fda.gov/nctr/science/centers/toxicoinformatics/maqc/), is a community-wide effort that aims to provide quality control tools to the microarray community in order to avoid procedural failures and to develop guidelines for microarray data analysis by providing the public with large reference datasets along with readily accessible reference RNA samples.
The results of phase 1 of the MAQC project, published in the September 2006 Nature Biotechnology special issue (http://www.nature.com/nbt/focus/maqc/index.html) have shown, between other things, that gene expression measurements showed inter- and intraplatform reproducibility.
The second phase of the MAQC project is primarily focused on predictive classifiers (signatures) for health outcomes based on microarray data. DNAVision has used its in-house developed tools (bioinformatics) for the quality control analyses of phase 2 datasets.